Audit 342609

FY End
2022-06-30
Total Expended
$1.25M
Findings
2
Programs
1
Organization: Mission Hospice & Home Care INC (CA)
Year: 2022 Accepted: 2025-02-14

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
523338 2022-003 Significant Deficiency - L
1099780 2022-003 Significant Deficiency - L

Programs

ALN Program Spent Major Findings
93.498 Provider Relief Fund and American Rescue Plan (arp) Rural Distribution $1.25M Yes 1

Contacts

Name Title Type
DAJ1W7636HK1 Jim Kelly Auditee
4155265520 Fadi Shahin Auditor
No contacts on file

Notes to SEFA

Title: 1. Basis of Presentation: Accounting Policies: 1. Basis of Presentation: The Schedule of Expenditures of Federal Awards (SEFA) includes the federal grant activity of Mission Hospice & Home Care (the "Agency") under programs of the federal government for the year ended June 30, 2022. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). 2. Basis of Accounting: Expenditures reported in the SEFA are presented on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Because SEFA presents only selected portion of the activities of the Agency, it is not intended to, and does not, present either the financial position, changes in net assets, or cash flows of the Agency. 3. Indirect Cost Rate: The Agency has not elected to use the 10% de minimis indirect cost rate as allowed under the Uniform Guidance. De Minimis Rate Used: N Rate Explanation: The Agency has not elected to use the 10% de minimis indirect cost rate as allowed under the Uniform Guidance. The Schedule of Expenditures of Federal Awards (SEFA) includes the federal grant activity of Mission Hospice & Home Care (the "Agency") under programs of the federal government for the year ended June 30, 2022. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance).
Title: 2. Basis of Accounting: Accounting Policies: 1. Basis of Presentation: The Schedule of Expenditures of Federal Awards (SEFA) includes the federal grant activity of Mission Hospice & Home Care (the "Agency") under programs of the federal government for the year ended June 30, 2022. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). 2. Basis of Accounting: Expenditures reported in the SEFA are presented on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Because SEFA presents only selected portion of the activities of the Agency, it is not intended to, and does not, present either the financial position, changes in net assets, or cash flows of the Agency. 3. Indirect Cost Rate: The Agency has not elected to use the 10% de minimis indirect cost rate as allowed under the Uniform Guidance. De Minimis Rate Used: N Rate Explanation: The Agency has not elected to use the 10% de minimis indirect cost rate as allowed under the Uniform Guidance. Expenditures reported in the SEFA are presented on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Because SEFA presents only selected portion of the activities of the Agency, it is not intended to, and does not, present either the financial position, changes in net assets, or cash flows of the Agency.
Title: 3. Indirect Cost Rate: Accounting Policies: 1. Basis of Presentation: The Schedule of Expenditures of Federal Awards (SEFA) includes the federal grant activity of Mission Hospice & Home Care (the "Agency") under programs of the federal government for the year ended June 30, 2022. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). 2. Basis of Accounting: Expenditures reported in the SEFA are presented on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Because SEFA presents only selected portion of the activities of the Agency, it is not intended to, and does not, present either the financial position, changes in net assets, or cash flows of the Agency. 3. Indirect Cost Rate: The Agency has not elected to use the 10% de minimis indirect cost rate as allowed under the Uniform Guidance. De Minimis Rate Used: N Rate Explanation: The Agency has not elected to use the 10% de minimis indirect cost rate as allowed under the Uniform Guidance. The Agency has not elected to use the 10% de minimis indirect cost rate as allowed under the Uniform Guidance.
Title: 4. COVID-19 Programs: Accounting Policies: 1. Basis of Presentation: The Schedule of Expenditures of Federal Awards (SEFA) includes the federal grant activity of Mission Hospice & Home Care (the "Agency") under programs of the federal government for the year ended June 30, 2022. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). 2. Basis of Accounting: Expenditures reported in the SEFA are presented on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Because SEFA presents only selected portion of the activities of the Agency, it is not intended to, and does not, present either the financial position, changes in net assets, or cash flows of the Agency. 3. Indirect Cost Rate: The Agency has not elected to use the 10% de minimis indirect cost rate as allowed under the Uniform Guidance. De Minimis Rate Used: N Rate Explanation: The Agency has not elected to use the 10% de minimis indirect cost rate as allowed under the Uniform Guidance. The expenditures for the COVID-19 Provider Relief Fund and related programs (Assistance Listing Number 93.498) are based on the terms and conditions established by HHS for eligible healthcare providers impacted by the pandemic.
Title: 5. Subrecipients: Accounting Policies: 1. Basis of Presentation: The Schedule of Expenditures of Federal Awards (SEFA) includes the federal grant activity of Mission Hospice & Home Care (the "Agency") under programs of the federal government for the year ended June 30, 2022. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). 2. Basis of Accounting: Expenditures reported in the SEFA are presented on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Because SEFA presents only selected portion of the activities of the Agency, it is not intended to, and does not, present either the financial position, changes in net assets, or cash flows of the Agency. 3. Indirect Cost Rate: The Agency has not elected to use the 10% de minimis indirect cost rate as allowed under the Uniform Guidance. De Minimis Rate Used: N Rate Explanation: The Agency has not elected to use the 10% de minimis indirect cost rate as allowed under the Uniform Guidance. The Agency does not provided federal awards to subrecipients.

Finding Details

Finding Title: Lack of Documented Evidence of Review Process for Reports Submitted to HRSA Federal Agency: U.S. Department of Health and Human Services (HHS) - Health Resources and Services Administration (HRSA) Federal Program: COVID-19 Provider Relief Fund Assistance Listing Number: 93.498 Award Year: January 1, 2022 to June 30, 2022 Compliance Requirement: Reporting Questioned Costs: N/A Type of Finding: A Significant Deficiency in Internal Control Over Compliance Criteria: The Uniform Guidance Compliance Supplement (2 CFR § 200.303) requires agencies to establish and maintain effective internal controls over federal awards to ensure compliance with statutes, regulations, and the terms of federal awards. Documented evidence of controls, such as review and approval processes, is critical for demonstrating compliance with federal reporting requirements. Condition: During testing of compliance controls, we noted that the Agency failed to provide documented evidence supporting the review and approval process for reports submitted to the Health Resources and Services Administration (HRSA). Management could not produce traceable records or evidence demonstrating that reports were reviewed for accuracy and completeness prior to submission. Cause: The deficiency arose from a lack of formalized processes and procedures requiring the documentation of review and approval steps for federal grant reporting. Contributing factors included inadequate oversight and insufficient training on federal grant compliance requirements. Effect: The absence of documented evidence of a review process increases the risk of errors or omissions in reports submitted to HRSA. This deficiency could result in non-compliance with federal reporting requirements, potentially jeopardizing the Agency's ability to demonstrate appropriate use of Provider Relief Fund (PRF) grant funds. Context: The Provider Relief Fund (PRF), established under the CARES Act, supports healthcare providers affected by the COVID-19 pandemic. Recipients of PRF funds are required to submit detailed reports to HRSA, ensuring accountability and transparency in the allocation of federal resources. A documented review process is essential to ensure that submitted reports accurately reflect the use of grant funds in compliance with federal requirements. Recommendation: We recommend that the Agency: - Develop and implement formalized procedures for the review and approval of federal grant reports before submission to HRSA. - Maintain traceable audit evidence, such as documented review checklists, signed approvals, and timestamps, to demonstrate compliance with federal reporting requirements. - Provide training to staff involved in the preparation and review of federal grant reports to ensure understanding of compliance requirements and the importance of documentation.
Finding Title: Lack of Documented Evidence of Review Process for Reports Submitted to HRSA Federal Agency: U.S. Department of Health and Human Services (HHS) - Health Resources and Services Administration (HRSA) Federal Program: COVID-19 Provider Relief Fund Assistance Listing Number: 93.498 Award Year: January 1, 2022 to June 30, 2022 Compliance Requirement: Reporting Questioned Costs: N/A Type of Finding: A Significant Deficiency in Internal Control Over Compliance Criteria: The Uniform Guidance Compliance Supplement (2 CFR § 200.303) requires agencies to establish and maintain effective internal controls over federal awards to ensure compliance with statutes, regulations, and the terms of federal awards. Documented evidence of controls, such as review and approval processes, is critical for demonstrating compliance with federal reporting requirements. Condition: During testing of compliance controls, we noted that the Agency failed to provide documented evidence supporting the review and approval process for reports submitted to the Health Resources and Services Administration (HRSA). Management could not produce traceable records or evidence demonstrating that reports were reviewed for accuracy and completeness prior to submission. Cause: The deficiency arose from a lack of formalized processes and procedures requiring the documentation of review and approval steps for federal grant reporting. Contributing factors included inadequate oversight and insufficient training on federal grant compliance requirements. Effect: The absence of documented evidence of a review process increases the risk of errors or omissions in reports submitted to HRSA. This deficiency could result in non-compliance with federal reporting requirements, potentially jeopardizing the Agency's ability to demonstrate appropriate use of Provider Relief Fund (PRF) grant funds. Context: The Provider Relief Fund (PRF), established under the CARES Act, supports healthcare providers affected by the COVID-19 pandemic. Recipients of PRF funds are required to submit detailed reports to HRSA, ensuring accountability and transparency in the allocation of federal resources. A documented review process is essential to ensure that submitted reports accurately reflect the use of grant funds in compliance with federal requirements. Recommendation: We recommend that the Agency: - Develop and implement formalized procedures for the review and approval of federal grant reports before submission to HRSA. - Maintain traceable audit evidence, such as documented review checklists, signed approvals, and timestamps, to demonstrate compliance with federal reporting requirements. - Provide training to staff involved in the preparation and review of federal grant reports to ensure understanding of compliance requirements and the importance of documentation.